p53 gene mutations in breast cancers in midwestern US women: Null as well as missense-type mutations are associated with poor prognosis

S. Saitoh, Julie M Cunningham, E. M G De Vries, R. M. McGovern, J. J. Schroeder, A. Hartmann, H. Blaszyk, L. E. Wold, Daniel J Schaid, S. S. Sommer, J. S. Kovach

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

We determined the pattern of mutations in exons 2-11 and adjacent intronic regions in breast cancers from Midwestern US white women. Twenty-one mutations were detected in 53 tumors (39.6%). Comparisons of the pattern of mutations within exons 5-9 showed that the frequency of missense mutations (44%) was lower in breast cancers of US Midwestern women than in most tumor types including breast cancers in other populations. Compared to breast cancers reported in a Scottish population, US women had a high frequency of microdeletion mutations (P = 0.006) and a low frequency of G:C→T:A transversions (P = 0.046). These findings suggest that environmental or endogenous factors contribute to p53 mutagenesis in mammary tissue to different extents among different populations. With a median follow-up of 19 months, the presence of a mutation was associated with shorter time to disease recurrence (P = 0.05) and shorter survival (P = 0.003). Putative dominant negative missense-type mutations (missense and in-frame microdeletions; P = 0.001) and null mutations (hemizygous nonsense and frameshift mutations; P = 0.007) were equally ominous. Thus, tumors with missense p53 mutations resulting in overexpression of a dysfunctional but otherwise intact protein have a clinical outcome similar to tumors with null mutations resulting in a truncated or garbled protein.

Original languageEnglish (US)
Pages (from-to)2869-2875
Number of pages7
JournalOncogene
Volume9
Issue number10
StatePublished - Oct 1994

Fingerprint

p53 Genes
Missense Mutation
Breast Neoplasms
Mutation
Exons
Neoplasms
Population
Frameshift Mutation
Nonsense Codon
Mutation Rate
Mutagenesis
Proteins
Breast
Recurrence
Survival

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Saitoh, S., Cunningham, J. M., De Vries, E. M. G., McGovern, R. M., Schroeder, J. J., Hartmann, A., ... Kovach, J. S. (1994). p53 gene mutations in breast cancers in midwestern US women: Null as well as missense-type mutations are associated with poor prognosis. Oncogene, 9(10), 2869-2875.

p53 gene mutations in breast cancers in midwestern US women : Null as well as missense-type mutations are associated with poor prognosis. / Saitoh, S.; Cunningham, Julie M; De Vries, E. M G; McGovern, R. M.; Schroeder, J. J.; Hartmann, A.; Blaszyk, H.; Wold, L. E.; Schaid, Daniel J; Sommer, S. S.; Kovach, J. S.

In: Oncogene, Vol. 9, No. 10, 10.1994, p. 2869-2875.

Research output: Contribution to journalArticle

Saitoh, S, Cunningham, JM, De Vries, EMG, McGovern, RM, Schroeder, JJ, Hartmann, A, Blaszyk, H, Wold, LE, Schaid, DJ, Sommer, SS & Kovach, JS 1994, 'p53 gene mutations in breast cancers in midwestern US women: Null as well as missense-type mutations are associated with poor prognosis', Oncogene, vol. 9, no. 10, pp. 2869-2875.
Saitoh, S. ; Cunningham, Julie M ; De Vries, E. M G ; McGovern, R. M. ; Schroeder, J. J. ; Hartmann, A. ; Blaszyk, H. ; Wold, L. E. ; Schaid, Daniel J ; Sommer, S. S. ; Kovach, J. S. / p53 gene mutations in breast cancers in midwestern US women : Null as well as missense-type mutations are associated with poor prognosis. In: Oncogene. 1994 ; Vol. 9, No. 10. pp. 2869-2875.
@article{a2fe63e4ef6944c08da45e8c950252dc,
title = "p53 gene mutations in breast cancers in midwestern US women: Null as well as missense-type mutations are associated with poor prognosis",
abstract = "We determined the pattern of mutations in exons 2-11 and adjacent intronic regions in breast cancers from Midwestern US white women. Twenty-one mutations were detected in 53 tumors (39.6{\%}). Comparisons of the pattern of mutations within exons 5-9 showed that the frequency of missense mutations (44{\%}) was lower in breast cancers of US Midwestern women than in most tumor types including breast cancers in other populations. Compared to breast cancers reported in a Scottish population, US women had a high frequency of microdeletion mutations (P = 0.006) and a low frequency of G:C→T:A transversions (P = 0.046). These findings suggest that environmental or endogenous factors contribute to p53 mutagenesis in mammary tissue to different extents among different populations. With a median follow-up of 19 months, the presence of a mutation was associated with shorter time to disease recurrence (P = 0.05) and shorter survival (P = 0.003). Putative dominant negative missense-type mutations (missense and in-frame microdeletions; P = 0.001) and null mutations (hemizygous nonsense and frameshift mutations; P = 0.007) were equally ominous. Thus, tumors with missense p53 mutations resulting in overexpression of a dysfunctional but otherwise intact protein have a clinical outcome similar to tumors with null mutations resulting in a truncated or garbled protein.",
author = "S. Saitoh and Cunningham, {Julie M} and {De Vries}, {E. M G} and McGovern, {R. M.} and Schroeder, {J. J.} and A. Hartmann and H. Blaszyk and Wold, {L. E.} and Schaid, {Daniel J} and Sommer, {S. S.} and Kovach, {J. S.}",
year = "1994",
month = "10",
language = "English (US)",
volume = "9",
pages = "2869--2875",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - p53 gene mutations in breast cancers in midwestern US women

T2 - Null as well as missense-type mutations are associated with poor prognosis

AU - Saitoh, S.

AU - Cunningham, Julie M

AU - De Vries, E. M G

AU - McGovern, R. M.

AU - Schroeder, J. J.

AU - Hartmann, A.

AU - Blaszyk, H.

AU - Wold, L. E.

AU - Schaid, Daniel J

AU - Sommer, S. S.

AU - Kovach, J. S.

PY - 1994/10

Y1 - 1994/10

N2 - We determined the pattern of mutations in exons 2-11 and adjacent intronic regions in breast cancers from Midwestern US white women. Twenty-one mutations were detected in 53 tumors (39.6%). Comparisons of the pattern of mutations within exons 5-9 showed that the frequency of missense mutations (44%) was lower in breast cancers of US Midwestern women than in most tumor types including breast cancers in other populations. Compared to breast cancers reported in a Scottish population, US women had a high frequency of microdeletion mutations (P = 0.006) and a low frequency of G:C→T:A transversions (P = 0.046). These findings suggest that environmental or endogenous factors contribute to p53 mutagenesis in mammary tissue to different extents among different populations. With a median follow-up of 19 months, the presence of a mutation was associated with shorter time to disease recurrence (P = 0.05) and shorter survival (P = 0.003). Putative dominant negative missense-type mutations (missense and in-frame microdeletions; P = 0.001) and null mutations (hemizygous nonsense and frameshift mutations; P = 0.007) were equally ominous. Thus, tumors with missense p53 mutations resulting in overexpression of a dysfunctional but otherwise intact protein have a clinical outcome similar to tumors with null mutations resulting in a truncated or garbled protein.

AB - We determined the pattern of mutations in exons 2-11 and adjacent intronic regions in breast cancers from Midwestern US white women. Twenty-one mutations were detected in 53 tumors (39.6%). Comparisons of the pattern of mutations within exons 5-9 showed that the frequency of missense mutations (44%) was lower in breast cancers of US Midwestern women than in most tumor types including breast cancers in other populations. Compared to breast cancers reported in a Scottish population, US women had a high frequency of microdeletion mutations (P = 0.006) and a low frequency of G:C→T:A transversions (P = 0.046). These findings suggest that environmental or endogenous factors contribute to p53 mutagenesis in mammary tissue to different extents among different populations. With a median follow-up of 19 months, the presence of a mutation was associated with shorter time to disease recurrence (P = 0.05) and shorter survival (P = 0.003). Putative dominant negative missense-type mutations (missense and in-frame microdeletions; P = 0.001) and null mutations (hemizygous nonsense and frameshift mutations; P = 0.007) were equally ominous. Thus, tumors with missense p53 mutations resulting in overexpression of a dysfunctional but otherwise intact protein have a clinical outcome similar to tumors with null mutations resulting in a truncated or garbled protein.

UR - http://www.scopus.com/inward/record.url?scp=0027935395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027935395&partnerID=8YFLogxK

M3 - Article

C2 - 8084591

AN - SCOPUS:0027935395

VL - 9

SP - 2869

EP - 2875

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 10

ER -